Approval · Notice of Compliance 23453 · 2020
IBSRELA: Notice of Compliance 23453
Issued April 15, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23453
- Date
- April 15, 2020
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBSRELA | 02498049 | Cancelled Post Market |
Medicinal ingredients
- TENAPANOR 50 MG per TAB